These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4165216)

  • 1. The clearing factor lipase (CFL) response to synthetic sulfonated polysaccharides in the rat.
    Monkhouse FC; Abbott EC
    Can J Physiol Pharmacol; 1966 Jul; 44(4):635-40. PubMed ID: 4165216
    [No Abstract]   [Full Text] [Related]  

  • 2. Activities of sulfated polysaccharides in the liberation of lipoprotein lipase into the blood and inhibition of its activity.
    Yasuoka S; Fujii S; Yamaguchi T; Sakurai K; Okuyama T
    J Biochem; 1973 Sep; 74(3):425-34. PubMed ID: 4756891
    [No Abstract]   [Full Text] [Related]  

  • 3. The dose-dependent effect of heparin and SP-54 on Triton-induced lipemia in rats.
    Solyom A; Cseh G; Villànyi K
    Life Sci; 1965 Jul; 4(14):1411-20. PubMed ID: 4158775
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thrombolytic drugs of a non-enzymatic nature (review of the literature)].
    Ivleva AIa; Zolotukhin SI
    Farmakol Toksikol; 1973; 36(3):359-65. PubMed ID: 4132908
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the behavior of the plasma "clearing factor" after the administration of a synthetic heparinoid].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1498-9. PubMed ID: 13807122
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research on lipoprotein lipase. I. Determination of the postheparin lipoprotein lipase ("clearing factor") in man by measurement of triglyceride splitting].
    SAILER S; SANDHOFER F; BRAUNSTEINER H
    Klin Wochenschr; 1961 Jun; 39():585-8. PubMed ID: 13745425
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of various vascular regions in the liberation of the clearing factor after injection of heparin].
    LEMARCHAND H; PARAMELLE B
    J Physiol (Paris); 1961; 53():408-9. PubMed ID: 13760715
    [No Abstract]   [Full Text] [Related]  

  • 8. [On influencing the physiological coagulation time and the clearing factor by total body inunction with alpha-heparin and heparinoid ointments].
    STUETTGEN G; BRUESTER H
    Dermatol Wochenschr; 1960 Jan; 141():97-102. PubMed ID: 13835417
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect on fat metabolism of a new heparinoid of fungal origin.
    Tamási G; Cseh G; Szabó IK; Villányi K
    Acta Physiol Acad Sci Hung; 1968; 33(2):205-12. PubMed ID: 4175991
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of deoxyribonucleic acid and heparinoid compounds on nucleic acid metabolism of the mouse].
    Tempel K
    Z Naturforsch B; 1969 Dec; 24(12):1550-5. PubMed ID: 4189413
    [No Abstract]   [Full Text] [Related]  

  • 11. [Postheparin esterase and clearing factor in liver diseases].
    STORK A; KUCEROVA L
    Cas Lek Cesk; 1962 Jul; 101():833-6. PubMed ID: 13917521
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides.
    Bengtsson G; Olivecrona T; Höök M; Riesenfeld J; Lindahl U
    Biochem J; 1980 Sep; 189(3):625-33. PubMed ID: 6452123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of various drugs and their action on lipids and the clearing factor].
    MOSSO HE; PERGOLA F; KATZ S
    Dia Med; 1962 Mar; 34():330-4. PubMed ID: 14476562
    [No Abstract]   [Full Text] [Related]  

  • 14. Observations on heparin-induced clearing activity in ischaemic heart disease and the effect of prolonged heparin therapy.
    NESTEL PJ
    Australas Ann Med; 1961 Feb; 10():29-32. PubMed ID: 13728417
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipoprotein lipase and liver triglyceride lipase in blood plasma of rabbits and rats subjected to heparin administration].
    Soliternova IB; Nikul'cheva NG
    Vopr Med Khim; 1982; 28(1):87-92. PubMed ID: 7064387
    [No Abstract]   [Full Text] [Related]  

  • 16. [In-vitro inhibition of thrombocyte aggregation induced by xenogenic serum].
    von Kaulla KN; Gerloff J
    Res Exp Med (Berl); 1972; 158(2):152-64. PubMed ID: 4116282
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ester-splitting enzymes of the human lung].
    Pilz W; Johann I
    Hoppe Seylers Z Physiol Chem; 1967 Jan; 348(1):73-83. PubMed ID: 4173900
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological profile of ateroid.
    Prino G
    Mod Probl Pharmacopsychiatry; 1989; 23():68-75. PubMed ID: 2469951
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heparin and lipoprotein lipase].
    MOSSO HE; PERGOLA F
    Dia Med; 1962 Mar; 34():220-2. PubMed ID: 14476563
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.